Shadow

Uro-Surgery

Surgical Recent Advances in Bladder Cancer

Surgical Recent Advances in Bladder Cancer

Uro-Surgery
Bladder cancer is the most expensive cancer to treat from diagnosis to death. Frequent disease recurrence, intense follow-up, and expensive, invasive techniques for diagnosis and treatment drive these costs for non-muscle invasive bladder cancer. Fluorescence cystoscopy increases the detection of superficial bladder cancer and reduces costs by improving the quality of resection and reducing recurrences. Radical cystectomy with intestinal diversion is the mainstay of treatment of invasive disease; however it is associated with substantial cost and morbidity. Increased efforts to improve the surgical management of bladder cancer while reducing the cost of treatment are increasingly necessary. Key points • Bladder cancer is one of the most expensive cancers to treat; however, funding...
Advances In Image-Guided Urologic Surgery

Advances In Image-Guided Urologic Surgery

Robotic Surgery, Uro-Surgery
Dr. Li-Ming Su, David A. Cofrin Chair of Endourology and Chief, Division of Robotic & Minimally Invasive Urologic Surgery and Dr. Joseph C. Liao, along with Springer has recently released Advances In Image-Guided Urologic Surgery.  This book provides an overview of the current state-of-art in combining advances in biomedical imaging with intraoperative navigation and preoperative planning for urologic surgery. These advances hold great promise in improving diagnostic and therapeutic urologic interventions to improve patient outcomes. Leading experts in this exciting emerging field covers early clinical and pre-clinical applications of optical, ultrasound, cross-sectional and computer-assisted imaging in urologic surgery. Advances in Image-Guided Urologic Surgery provides a unique and v...